Aclaris Therapeutics
ACRS
ACRS
100 hedge funds and large institutions have $536M invested in Aclaris Therapeutics in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
-2
Holders Change %
-1.96%
% of All Funds
2.3%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
14
Increased
46
Reduced
28
Closed
15
Calls
–
Puts
$254K
Net Calls
-$254K
Net Calls Change
+$1.22M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$15.7M |
| 2 |
DM
2
Deerfield Management
New York
|
$48.1M |
| 3 |
PC
3
Polar Capital
London,
United Kingdom
|
$28.9M |
| 4 |
4
D.E. Shaw & Co
New York
|
$21.7M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$3.33M |
